Skip to main content
LMED
OTC Technology

LataMed AI Q2: Going Concern, Zero Cash, and a Super-Voting Preferred Share Shuffle

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Technology
Sentiment info
Negative
Importance info
9
Price
$0.66
Mkt Cap
$119.245M
52W Low
$0.053
52W High
$135.002
52W Position info
1145% above low
Off High info
100% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

LMED has more than doubled off its 52-week low of $0.053 on light trading volume (0.3× avg).

Summary

LataMed AI Corp. reported zero revenue, a going concern warning, and material weaknesses in its Q2 10-Q. The company issued super-voting preferred stock and acquired intangible assets for shares, while a pending forward stock split and authorized share increase signal potential for heavy dilution.


Key Events · Earnings and Guidance · LMED

  • Going Concern and No Cash

    With zero cash, a $140,221 net loss for H1 2026, and an accumulated deficit of $29.7 million, management expresses substantial doubt about the company's ability to continue as a going concern.

  • Material Weakness in Controls

    Disclosure controls and procedures were not effective due to limited internal resources and lack of multiple levels of transaction review.

  • Super-Voting Preferred Stock Issued

    A shareholder received 5,000,000 shares of Series C Preferred Stock in exchange for canceling 20,000,000 common shares. Each Series C share carries 20 votes, concentrating voting control.

  • Intangible Asset Acquisition

    The company issued 12,000,000 common shares (valued at $7.8 million by management) for proprietary assets and intellectual property, with no independent valuation disclosed.


Analysis · LMED · Technology

LataMed AI Corp. remains a pre-revenue shell with no cash, a going concern warning, and material weaknesses in its financial controls. The company issued 5 million super-voting Series C preferred shares to a shareholder in exchange for canceling 20 million common shares, concentrating voting power. It also acquired $7.8 million in intangible assets for stock, but the value is entirely management-estimated. With $771,000 in current liabilities and no revenue, survival depends on raising capital—likely through the massive authorized share increase and pending forward stock split, which could enable highly dilutive financing.

At the time of this filing, LMED was trading at $0.66 on OTC in the Technology sector, with a market capitalization of approximately $119.2M. The 52-week trading range was $0.05 to $135.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LMED - Latest Insights

LMED
Jul 08, 2026, 7:05 AM EDT
Source: EQS
Importance Score:
7
Price at Filing: $3.85
Real-time Price: $0.660 info
Change: Stock Split info
Market Cap: $119.245M info
LMED
Jun 30, 2026, 8:53 AM EDT
Source: EQS
Importance Score:
7
Price at Filing: $3.55
Real-time Price: $0.660 info
Change: Stock Split info
Market Cap: $119.245M info
LMED
Jun 15, 2026, 9:05 AM EDT
Source: EQS
Importance Score:
7
Price at Filing: $2.44
Real-time Price: $0.660 info
Change: Stock Split info
Market Cap: $119.245M info
LMED
May 20, 2026, 2:30 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.73
Real-time Price: $0.660 info
Change: Stock Split info
Market Cap: $119.245M info
LMED
May 14, 2026, 9:36 AM EDT
Source: EQS
Importance Score:
7
Price at Filing: $2.53
Real-time Price: $0.660 info
Change: Stock Split info
Market Cap: $119.245M info